Racial disparities in opioid prescriptions for fractures in the pediatric population

Emily Wing1, Soheil Saadat1, Rishi Bhargava2

  • 1University of California, Irvine, 333 City Boulevard West Suite 640, Orange, CA 92868, USA.

Insights

Racial disparities exist in pediatric opioid prescriptions for fractures. Non-Hispanic White children were more likely to receive opioid pain medication compared to Black and Hispanic White children.

Area of Science:

  • Pediatric Pain Management
  • Health Disparities
  • Pharmacology

Background:

  • Racial disparities in pain management are documented.
  • Limited research exists on these disparities in pediatric populations.
  • This study addresses the gap in understanding racial influences on pediatric pain management.

Purpose of the Study:

  • To investigate the association between race and opioid prescription patterns in pediatric patients diagnosed with fractures.
  • To identify potential racial biases in pain management for children.

Main Methods:

  • Retrospective analysis of analgesic prescriptions for pediatric patients (0-21 years) discharged over five years.
  • Inclusion criteria: patients with a fracture diagnosis.
  • Statistical analysis: Multiple logistic regression to adjust for covariates.

Main Results:

  • 58,402 prescriptions reviewed; 5,061 for fractures.
  • 52% of fracture prescriptions were for opioids.
  • Non-Hispanic White patients had 1.44 times higher odds of receiving opioid prescriptions compared to Black patients, adjusted for covariates.

Conclusions:

  • Evidence suggests racial bias in pediatric opioid prescribing for fractures.
  • Disparities may lead to negative downstream health effects.
  • Need for standardized pain management protocols to reduce prescriber variability.
Abstract

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
900
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
22
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
35
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
24
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
506
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
21